Endonovo Therapeutics Market Cap

Endonovo Therapeutics has a market cap or net worth of $180.76 thousand as of March 6, 2026. Its market cap has decreased by -49.39% in one year.

Market Cap

180.76K

Enterprise Value

n/a

Revenue

255.72K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 180.76K, an increase of 129.10%. That is a compound annual growth rate of 6.56%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	180.76K	-
Dec 31, 2025	180.76K	-16.91%
Dec 31, 2024	217.55K	-92.16%
Dec 29, 2023	2.77M	-20.72%
Dec 30, 2022	3.50M	211.37%
Dec 31, 2021	1.12M	127.79%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Regen BioPharma	178.35K
Ocean Biomedical	162.66K
GB Sciences	153.72K
CNBX Pharmaceuticals	225.15K
Immunotech Laboratories	114.99K
Synairgen	110.27K
Ampio Pharmaceuticals	332.15K
THC Farmaceuticals	380.76K

Market Cap Rankings